InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2026-04-01 17:05:12 ET · period of report 2026-03-31 · accession 0001936799-26-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-04-01 17:05 2026-03-31 INO Sumner Michael John Chief Medical Off M - OptEx — +4,292 34.8K +14% —
D 2026-04-01 17:05 2026-03-31 INO Sumner Michael John Chief Medical Off F - Tax $1.74 -1,223 33.6K -4% -$2,128
D 2026-04-01 17:05 2026-03-31 INO Sumner Michael John Chief Medical Off M - OptEx $0.00 -4,292 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-31 M A 4,292 — 34,799 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026.
2 Common Common Stock 2026-03-31 F D 1,223 $1.74 33,576 D — — (F2) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
3 Derivative Restricted Stock Unit 2026-03-31 M D 4,292 $0.00 0 D — · — to — 4,292 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026.